AST5902 is the principal metabolite of alflutinib both in vitro and in vivo, which exerts remarkable antineoplastic activity similar to alflutinib. AST5902 exhibits much weak CYP3A4 induction potential compared to alflutinib.
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
AST5902 is the principal metabolite of alflutinib both in vitro and in vivo, which exerts remarkable antineoplastic activity similar to alflutinib. AST5902 exhibits much weak CYP3A4 induction potential compared to alflutinib.
[1] Xiao-Yun Liu, et al. Acta Pharmacol Sin. 2020 Oct;41(10):1366-1376.
没有评价数据